Winch Advisory Services’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07K | Hold |
1,000
| – | – | ﹤0.01% | 406 |
|
|
2025
Q1 | $2.2K | Hold |
1,000
| – | – | ﹤0.01% | 408 |
|
|
2024
Q4 | $1.53K | Hold |
1,000
| – | – | ﹤0.01% | 460 |
|
|
2024
Q3 | $1.99K | Hold |
1,000
| – | – | ﹤0.01% | 377 |
|
|
2024
Q2 | $3.5K | Hold |
1,000
| – | – | ﹤0.01% | 339 |
|
|
2024
Q1 | $2.77K | Hold |
1,000
| – | – | ﹤0.01% | 351 |
|
|
2023
Q4 | $1.7K | Hold |
1,000
| – | – | ﹤0.01% | 372 |
|
|
2023
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 393 |
|
|
2023
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 393 |
|
|
2023
Q1 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 353 |
|
|
2022
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 316 |
|
|
2022
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 284 |
|
|
2022
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 324 |
|
|
2022
Q1 | $6K | Hold |
1,000
| – | – | ﹤0.01% | 299 |
|
|
2021
Q4 | $9K | Hold |
1,000
| – | – | ﹤0.01% | 271 |
|
|
2021
Q3 | $11K | Hold |
1,000
| – | – | ﹤0.01% | 263 |
|
|
2021
Q2 | $16K | Hold |
1,000
| – | – | 0.01% | 231 |
|
|
2021
Q1 | $16K | Hold |
1,000
| – | – | 0.01% | 209 |
|
|
2020
Q4 | $21K | Hold |
1,000
| – | – | 0.01% | 156 |
|
|
2020
Q3 | $15K | Hold |
1,000
| – | – | 0.01% | 168 |
|
|
2020
Q2 | $15K | Buy |
+1,000
| New | +$15K | 0.01% | 159 |
|
|
2020
Q1 | – | Sell |
-939
| Closed | -$22K | – | 360 |
|
|
2019
Q4 | $22K | Hold |
939
| – | – | 0.01% | 150 |
|
|
2019
Q3 | $17K | Buy |
+939
| New | +$17K | 0.01% | 153 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$3K | – | 352 |
|
|
2018
Q1 | $3K | Sell |
100
-200
| -67% | -$6K | ﹤0.01% | 248 |
|
|
2017
Q4 | $5K | Buy |
+300
| New | +$5K | ﹤0.01% | 219 |
|